Reglan and Nimbex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Reglan (metoclopramide hydrochloride) and Nimbex (cisatracurium besylate). Common drug interactions include dermatitis exfoliative among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Reglan and Nimbex. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

What is Nimbex?

Nimbex has active ingredients of cisatracurium besylate. eHealthMe is studying from 1,546 Nimbex users. Check the latest studies of Nimbex.



On Jul, 09, 2026

13 people who take Reglan and Nimbex together, and have interactions are studied.

Reglan and Nimbex drug interactions.

What are the common drug interactions of Reglan and Nimbex, by gender? *:

female:

  1. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Diplopia (double vision)
  4. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  5. Dizziness (excl vertigo)
  6. Dysuria (painful or difficult urination)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Diarrhoea
  9. Encephalopathy (functioning of the brain is affected by some agent or condition)
  10. Pleural effusion (water on the lungs)

male:

  1. Anxiety
  2. Emotional distress
  3. Hypotension (abnormally low blood pressure)
  4. Psychiatric symptom
  5. Psychological trauma
  6. Fear
  7. Injury
  8. Pain
  9. Renal failure (kidney dysfunction)
  10. Renal impairment (severely reduced kidney function)

What are the common drug interactions of Reglan and Nimbex, by age (0-1 to 60+)? *:

0-1:

  1. Capillary leak syndrome (capillary leaks plasma)
  2. Hypotension (abnormally low blood pressure)

2-9:

  1. Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
  2. Diarrhoea
  3. Diarrhoea haemorrhagic (bloody diarrhoea)
  4. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Pleural effusion (water on the lungs)
  7. Pyrexia (fever)
  8. Septic shock (shock due to blood infection)
  9. Tooth abscess (pus formation in tooth)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Oedema (fluid collection in tissue)
  2. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  3. Pneumonia
  4. Proctalgia (pain in the rectum)
  5. Proteinuria (presence of protein in the urine)
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Rales (an abnormal respiratory sound characterized by fine crackles)
  8. Renal tubular necrosis (death of kidney tubules)
  9. Respiratory distress (difficulty in breathing)
  10. Retinopathy hypertensive (acute damage to the retina of the eye due to high blood pressure)

50-59:

  1. Abdominal distension
  2. Abdominal pain
  3. Abdominal pain upper
  4. Adrenal mass
  5. Agitation (state of anxiety or nervous excitement)
  6. Back pain
  7. Chest pain
  8. Deafness unilateral
  9. Dementia (madness)
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Renal impairment (severely reduced kidney function)
  4. Renal injury (kidney injury)
  5. Stress
  6. Blood bilirubin increased
  7. Coombs direct test positive
  8. Flushing (the warm, red condition of human skin)
  9. Haematocrit decreased
  10. Haemoglobin decreased

What are the existing conditions these people have? *

  1. Hypotension (abnormally low blood pressure): 3 people, 23.08%
  2. Constipation: 3 people, 23.08%
  3. Fluid Overload (too much fluid in the blood): 2 people, 15.38%
  4. Nausea (feeling of having an urge to vomit): 2 people, 15.38%
  5. Pain: 2 people, 15.38%
  6. Ill-Defined Disorder: 2 people, 15.38%
  7. Chest Pain: 2 people, 15.38%
  8. Sedation: 2 people, 15.38%
  9. Hyperkalemia (damage to or disease of the kidney): 2 people, 15.38%
  10. Adenovirus Infection: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Reglan and Nimbex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Reglan and Nimbex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nimbex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reglan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nimbex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride and cisatracurium besylate (the active ingredients of Reglan and Nimbex, respectively), and Reglan and Nimbex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: